🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
It is a national, retrospective , observational study in hypertensive patie...
Status
Completed
Location
Boehringer Ingelheim Investigator site 1
Start Date
2009-05
Trial ID
NCT00909038
1. Objectives and Hypothesis 1. Objectives: This study evaluates...
Status
Unknown
Location
Jichi Medical Univercity
Start Date
2010-10
Trial ID
NCT01198496
Treatments Being Tested
The primary objective of this trial is to demonstrate that a fixed dose com...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2005-10
Trial ID
NCT00239369
1. To investigate the dose response of the combination therapy, Telmisartan...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2004-06
Trial ID
NCT00153049
Treatments Being Tested
Study to evaluate efficacy and tolerability of Micardis®/MicardisPlus® unde...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT02262637
Treatments Being Tested
A study to demonstrate the bioequivalence of telmisartan and HCTZ administe...
Status
Completed
Location
Multiple Locations
Start Date
1999-10
Trial ID
NCT02187523
Treatments Being Tested
To compare the pharmacokinetics and safety after a single dose administrati...
Status
Completed
Location
Chungbuk National University Hospital
Start Date
2021-07-08
Trial ID
NCT05040880
Treatments Being Tested
To assess the efficacy of telmisartan in hypertensive patients with high ca...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00890084
Treatments Being Tested
To investigate the steady state pharmacokinetics of different formulation o...
Status
Completed
Location
Boehringer Ingelheim Investigational Site
Start Date
2014-05
Trial ID
NCT02129192
Treatments Being Tested
The primary objective of this study is to compare the medication adherence ...
Status
Withdrawn
Location
Nippon Boehringer Ingelheim Co., Ltd.
Start Date
2022-06-01
Trial ID
NCT03205137